Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Up 148.8% in December

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) was the target of a large increase in short interest in December. As of December 31st, there was short interest totalling 220,700 shares, an increase of 148.8% from the December 15th total of 88,700 shares. Approximately 3.1% of the company’s stock are short sold. Based on an average daily volume of 470,100 shares, the short-interest ratio is currently 0.5 days.

Sol-Gel Technologies Trading Up 1.0 %

SLGL stock traded up $0.01 during mid-day trading on Tuesday, hitting $1.24. 381,194 shares of the company were exchanged, compared to its average volume of 651,171. The company has a market capitalization of $34.62 million, a PE ratio of -3.66 and a beta of 1.34. Sol-Gel Technologies has a twelve month low of $0.33 and a twelve month high of $1.65. The firm has a fifty day simple moving average of $0.71 and a 200 day simple moving average of $0.67.

Sol-Gel Technologies Company Profile

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.